CommercialCoverageMedium impact
Radiofrequency Volumetric Tissue Reduction for Nasal Obstruction
Blue Cross & Blue Shield of Mississippi·MS · ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Apr 15, 2025
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has classified radiofrequency volumetric tissue reduction for nasal obstruction (VivAer Stylus procedure) as investigational and not covered. This new policy affects ENT procedures for treating nasal valve collapse using RF energy devices.
Action Required
By April 15, 2025: Billing teams must flag all radiofrequency volumetric tissue reduction procedures for nasal obstruction as non-covered/investigational for BCBS Mississippi members. Update system to deny or require patient financial responsibility discussions before scheduling VivAer Stylus procedures. Notify ENT providers that these procedures will not be reimbursed by BCBS Mississippi.